1 Study Coverage
    1.1 Obesity Treating Neuromodulation System Product Introduction
    1.2 Market by Type
        1.2.1 Global Obesity Treating Neuromodulation System Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Vagus Nerve Stimulator
        1.2.3 Splanchnic Nerve Stimulator
        1.2.4 Deep Brain Stimulator
        1.2.5 Spinal Cord Stimulator
        1.2.6 Autonomous Nerve Stimulator
        1.2.7 Others
    1.3 Market by Application
        1.3.1 Global Obesity Treating Neuromodulation System Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Ambulatory Surgical Centers
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Obesity Treating Neuromodulation System Sales Estimates and Forecasts 2017-2028
    2.2 Global Obesity Treating Neuromodulation System Revenue Estimates and Forecasts 2017-2028
    2.3 Global Obesity Treating Neuromodulation System Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Obesity Treating Neuromodulation System Sales by Region
        2.4.1 Global Obesity Treating Neuromodulation System Sales by Region (2017-2022)
        2.4.2 Global Sales Obesity Treating Neuromodulation System by Region (2023-2028)
    2.5 Global Obesity Treating Neuromodulation System Revenue by Region
        2.5.1 Global Obesity Treating Neuromodulation System Revenue by Region (2017-2022)
        2.5.2 Global Obesity Treating Neuromodulation System Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Obesity Treating Neuromodulation System Sales by Manufacturers
        3.1.1 Global Top Obesity Treating Neuromodulation System Manufacturers by Sales (2017-2022)
        3.1.2 Global Obesity Treating Neuromodulation System Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Obesity Treating Neuromodulation System in 2021
    3.2 Global Obesity Treating Neuromodulation System Revenue by Manufacturers
        3.2.1 Global Obesity Treating Neuromodulation System Revenue by Manufacturers (2017-2022)
        3.2.2 Global Obesity Treating Neuromodulation System Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Obesity Treating Neuromodulation System Revenue in 2021
    3.3 Global Obesity Treating Neuromodulation System Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Obesity Treating Neuromodulation System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Obesity Treating Neuromodulation System Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Obesity Treating Neuromodulation System Sales by Type
        4.1.1 Global Obesity Treating Neuromodulation System Historical Sales by Type (2017-2022)
        4.1.2 Global Obesity Treating Neuromodulation System Forecasted Sales by Type (2023-2028)
        4.1.3 Global Obesity Treating Neuromodulation System Sales Market Share by Type (2017-2028)
    4.2 Global Obesity Treating Neuromodulation System Revenue by Type
        4.2.1 Global Obesity Treating Neuromodulation System Historical Revenue by Type (2017-2022)
        4.2.2 Global Obesity Treating Neuromodulation System Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Obesity Treating Neuromodulation System Revenue Market Share by Type (2017-2028)
    4.3 Global Obesity Treating Neuromodulation System Price by Type
        4.3.1 Global Obesity Treating Neuromodulation System Price by Type (2017-2022)
        4.3.2 Global Obesity Treating Neuromodulation System Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Obesity Treating Neuromodulation System Sales by Application
        5.1.1 Global Obesity Treating Neuromodulation System Historical Sales by Application (2017-2022)
        5.1.2 Global Obesity Treating Neuromodulation System Forecasted Sales by Application (2023-2028)
        5.1.3 Global Obesity Treating Neuromodulation System Sales Market Share by Application (2017-2028)
    5.2 Global Obesity Treating Neuromodulation System Revenue by Application
        5.2.1 Global Obesity Treating Neuromodulation System Historical Revenue by Application (2017-2022)
        5.2.2 Global Obesity Treating Neuromodulation System Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Obesity Treating Neuromodulation System Revenue Market Share by Application (2017-2028)
    5.3 Global Obesity Treating Neuromodulation System Price by Application
        5.3.1 Global Obesity Treating Neuromodulation System Price by Application (2017-2022)
        5.3.2 Global Obesity Treating Neuromodulation System Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Obesity Treating Neuromodulation System Market Size by Type
        6.1.1 North America Obesity Treating Neuromodulation System Sales by Type (2017-2028)
        6.1.2 North America Obesity Treating Neuromodulation System Revenue by Type (2017-2028)
    6.2 North America Obesity Treating Neuromodulation System Market Size by Application
        6.2.1 North America Obesity Treating Neuromodulation System Sales by Application (2017-2028)
        6.2.2 North America Obesity Treating Neuromodulation System Revenue by Application (2017-2028)
    6.3 North America Obesity Treating Neuromodulation System Market Size by Country
        6.3.1 North America Obesity Treating Neuromodulation System Sales by Country (2017-2028)
        6.3.2 North America Obesity Treating Neuromodulation System Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Obesity Treating Neuromodulation System Market Size by Type
        7.1.1 Europe Obesity Treating Neuromodulation System Sales by Type (2017-2028)
        7.1.2 Europe Obesity Treating Neuromodulation System Revenue by Type (2017-2028)
    7.2 Europe Obesity Treating Neuromodulation System Market Size by Application
        7.2.1 Europe Obesity Treating Neuromodulation System Sales by Application (2017-2028)
        7.2.2 Europe Obesity Treating Neuromodulation System Revenue by Application (2017-2028)
    7.3 Europe Obesity Treating Neuromodulation System Market Size by Country
        7.3.1 Europe Obesity Treating Neuromodulation System Sales by Country (2017-2028)
        7.3.2 Europe Obesity Treating Neuromodulation System Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Obesity Treating Neuromodulation System Market Size by Type
        8.1.1 Asia Pacific Obesity Treating Neuromodulation System Sales by Type (2017-2028)
        8.1.2 Asia Pacific Obesity Treating Neuromodulation System Revenue by Type (2017-2028)
    8.2 Asia Pacific Obesity Treating Neuromodulation System Market Size by Application
        8.2.1 Asia Pacific Obesity Treating Neuromodulation System Sales by Application (2017-2028)
        8.2.2 Asia Pacific Obesity Treating Neuromodulation System Revenue by Application (2017-2028)
    8.3 Asia Pacific Obesity Treating Neuromodulation System Market Size by Region
        8.3.1 Asia Pacific Obesity Treating Neuromodulation System Sales by Region (2017-2028)
        8.3.2 Asia Pacific Obesity Treating Neuromodulation System Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Obesity Treating Neuromodulation System Market Size by Type
        9.1.1 Latin America Obesity Treating Neuromodulation System Sales by Type (2017-2028)
        9.1.2 Latin America Obesity Treating Neuromodulation System Revenue by Type (2017-2028)
    9.2 Latin America Obesity Treating Neuromodulation System Market Size by Application
        9.2.1 Latin America Obesity Treating Neuromodulation System Sales by Application (2017-2028)
        9.2.2 Latin America Obesity Treating Neuromodulation System Revenue by Application (2017-2028)
    9.3 Latin America Obesity Treating Neuromodulation System Market Size by Country
        9.3.1 Latin America Obesity Treating Neuromodulation System Sales by Country (2017-2028)
        9.3.2 Latin America Obesity Treating Neuromodulation System Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Obesity Treating Neuromodulation System Market Size by Type
        10.1.1 Middle East and Africa Obesity Treating Neuromodulation System Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Obesity Treating Neuromodulation System Revenue by Type (2017-2028)
    10.2 Middle East and Africa Obesity Treating Neuromodulation System Market Size by Application
        10.2.1 Middle East and Africa Obesity Treating Neuromodulation System Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Obesity Treating Neuromodulation System Revenue by Application (2017-2028)
    10.3 Middle East and Africa Obesity Treating Neuromodulation System Market Size by Country
        10.3.1 Middle East and Africa Obesity Treating Neuromodulation System Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Obesity Treating Neuromodulation System Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Medtronic
        11.1.1 Medtronic Corporation Information
        11.1.2 Medtronic Overview
        11.1.3 Medtronic Obesity Treating Neuromodulation System Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Medtronic Obesity Treating Neuromodulation System Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Medtronic Recent Developments
    11.2 Cyberonics
        11.2.1 Cyberonics Corporation Information
        11.2.2 Cyberonics Overview
        11.2.3 Cyberonics Obesity Treating Neuromodulation System Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Cyberonics Obesity Treating Neuromodulation System Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Cyberonics Recent Developments
    11.3 Abbott
        11.3.1 Abbott Corporation Information
        11.3.2 Abbott Overview
        11.3.3 Abbott Obesity Treating Neuromodulation System Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Abbott Obesity Treating Neuromodulation System Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Abbott Recent Developments
    11.4 BioControl Medical
        11.4.1 BioControl Medical Corporation Information
        11.4.2 BioControl Medical Overview
        11.4.3 BioControl Medical Obesity Treating Neuromodulation System Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 BioControl Medical Obesity Treating Neuromodulation System Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 BioControl Medical Recent Developments
    11.5 Leptos Medical
        11.5.1 Leptos Medical Corporation Information
        11.5.2 Leptos Medical Overview
        11.5.3 Leptos Medical Obesity Treating Neuromodulation System Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Leptos Medical Obesity Treating Neuromodulation System Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Leptos Medical Recent Developments
    11.6 ReShape Lifesciences
        11.6.1 ReShape Lifesciences Corporation Information
        11.6.2 ReShape Lifesciences Overview
        11.6.3 ReShape Lifesciences Obesity Treating Neuromodulation System Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 ReShape Lifesciences Obesity Treating Neuromodulation System Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 ReShape Lifesciences Recent Developments
    11.7 Nevro
        11.7.1 Nevro Corporation Information
        11.7.2 Nevro Overview
        11.7.3 Nevro Obesity Treating Neuromodulation System Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Nevro Obesity Treating Neuromodulation System Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Nevro Recent Developments
    11.8 Nuvectra
        11.8.1 Nuvectra Corporation Information
        11.8.2 Nuvectra Overview
        11.8.3 Nuvectra Obesity Treating Neuromodulation System Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 Nuvectra Obesity Treating Neuromodulation System Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Nuvectra Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Obesity Treating Neuromodulation System Industry Chain Analysis
    12.2 Obesity Treating Neuromodulation System Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Obesity Treating Neuromodulation System Production Mode & Process
    12.4 Obesity Treating Neuromodulation System Sales and Marketing
        12.4.1 Obesity Treating Neuromodulation System Sales Channels
        12.4.2 Obesity Treating Neuromodulation System Distributors
    12.5 Obesity Treating Neuromodulation System Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Obesity Treating Neuromodulation System Industry Trends
    13.2 Obesity Treating Neuromodulation System Market Drivers
    13.3 Obesity Treating Neuromodulation System Market Challenges
    13.4 Obesity Treating Neuromodulation System Market Restraints
14 Key Findings in The Global Obesity Treating Neuromodulation System Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Obesity Treating Neuromodulation System Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Vagus Nerve Stimulator
    Table 3. Major Manufacturers of Splanchnic Nerve Stimulator
    Table 4. Major Manufacturers of Deep Brain Stimulator
    Table 5. Major Manufacturers of Spinal Cord Stimulator
    Table 6. Major Manufacturers of Autonomous Nerve Stimulator
    Table 7. Major Manufacturers of Others
    Table 8. Global Obesity Treating Neuromodulation System Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 9. Global Obesity Treating Neuromodulation System Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 10. Global Obesity Treating Neuromodulation System Sales by Region (2017-2022) & (K Units)
    Table 11. Global Obesity Treating Neuromodulation System Sales Market Share by Region (2017-2022)
    Table 12. Global Obesity Treating Neuromodulation System Sales by Region (2023-2028) & (K Units)
    Table 13. Global Obesity Treating Neuromodulation System Sales Market Share by Region (2023-2028)
    Table 14. Global Obesity Treating Neuromodulation System Revenue by Region (2017-2022) & (US$ Million)
    Table 15. Global Obesity Treating Neuromodulation System Revenue Market Share by Region (2017-2022)
    Table 16. Global Obesity Treating Neuromodulation System Revenue by Region (2023-2028) & (US$ Million)
    Table 17. Global Obesity Treating Neuromodulation System Revenue Market Share by Region (2023-2028)
    Table 18. Global Obesity Treating Neuromodulation System Sales by Manufacturers (2017-2022) & (K Units)
    Table 19. Global Obesity Treating Neuromodulation System Sales Share by Manufacturers (2017-2022)
    Table 20. Global Obesity Treating Neuromodulation System Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 21. Global Obesity Treating Neuromodulation System Revenue Share by Manufacturers (2017-2022)
    Table 22. Obesity Treating Neuromodulation System Price by Manufacturers (2017-2022) &(USD/Unit)
    Table 23. Global Obesity Treating Neuromodulation System Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 24. Global Obesity Treating Neuromodulation System by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Obesity Treating Neuromodulation System as of 2021)
    Table 25. Obesity Treating Neuromodulation System Manufacturing Base Distribution and Headquarters
    Table 26. Manufacturers Obesity Treating Neuromodulation System Product Offered
    Table 27. Date of Manufacturers Enter into Obesity Treating Neuromodulation System Market
    Table 28. Mergers & Acquisitions, Expansion Plans
    Table 29. Global Obesity Treating Neuromodulation System Sales by Type (2017-2022) & (K Units)
    Table 30. Global Obesity Treating Neuromodulation System Sales by Type (2023-2028) & (K Units)
    Table 31. Global Obesity Treating Neuromodulation System Sales Share by Type (2017-2022)
    Table 32. Global Obesity Treating Neuromodulation System Sales Share by Type (2023-2028)
    Table 33. Global Obesity Treating Neuromodulation System Revenue by Type (2017-2022) & (US$ Million)
    Table 34. Global Obesity Treating Neuromodulation System Revenue by Type (2023-2028) & (US$ Million)
    Table 35. Global Obesity Treating Neuromodulation System Revenue Share by Type (2017-2022)
    Table 36. Global Obesity Treating Neuromodulation System Revenue Share by Type (2023-2028)
    Table 37. Obesity Treating Neuromodulation System Price by Type (2017-2022) & (USD/Unit)
    Table 38. Global Obesity Treating Neuromodulation System Price Forecast by Type (2023-2028) & (USD/Unit)
    Table 39. Global Obesity Treating Neuromodulation System Sales by Application (2017-2022) & (K Units)
    Table 40. Global Obesity Treating Neuromodulation System Sales by Application (2023-2028) & (K Units)
    Table 41. Global Obesity Treating Neuromodulation System Sales Share by Application (2017-2022)
    Table 42. Global Obesity Treating Neuromodulation System Sales Share by Application (2023-2028)
    Table 43. Global Obesity Treating Neuromodulation System Revenue by Application (2017-2022) & (US$ Million)
    Table 44. Global Obesity Treating Neuromodulation System Revenue by Application (2023-2028) & (US$ Million)
    Table 45. Global Obesity Treating Neuromodulation System Revenue Share by Application (2017-2022)
    Table 46. Global Obesity Treating Neuromodulation System Revenue Share by Application (2023-2028)
    Table 47. Obesity Treating Neuromodulation System Price by Application (2017-2022) & (USD/Unit)
    Table 48. Global Obesity Treating Neuromodulation System Price Forecast by Application (2023-2028) & (USD/Unit)
    Table 49. North America Obesity Treating Neuromodulation System Sales by Type (2017-2022) & (K Units)
    Table 50. North America Obesity Treating Neuromodulation System Sales by Type (2023-2028) & (K Units)
    Table 51. North America Obesity Treating Neuromodulation System Revenue by Type (2017-2022) & (US$ Million)
    Table 52. North America Obesity Treating Neuromodulation System Revenue by Type (2023-2028) & (US$ Million)
    Table 53. North America Obesity Treating Neuromodulation System Sales by Application (2017-2022) & (K Units)
    Table 54. North America Obesity Treating Neuromodulation System Sales by Application (2023-2028) & (K Units)
    Table 55. North America Obesity Treating Neuromodulation System Revenue by Application (2017-2022) & (US$ Million)
    Table 56. North America Obesity Treating Neuromodulation System Revenue by Application (2023-2028) & (US$ Million)
    Table 57. North America Obesity Treating Neuromodulation System Sales by Country (2017-2022) & (K Units)
    Table 58. North America Obesity Treating Neuromodulation System Sales by Country (2023-2028) & (K Units)
    Table 59. North America Obesity Treating Neuromodulation System Revenue by Country (2017-2022) & (US$ Million)
    Table 60. North America Obesity Treating Neuromodulation System Revenue by Country (2023-2028) & (US$ Million)
    Table 61. Europe Obesity Treating Neuromodulation System Sales by Type (2017-2022) & (K Units)
    Table 62. Europe Obesity Treating Neuromodulation System Sales by Type (2023-2028) & (K Units)
    Table 63. Europe Obesity Treating Neuromodulation System Revenue by Type (2017-2022) & (US$ Million)
    Table 64. Europe Obesity Treating Neuromodulation System Revenue by Type (2023-2028) & (US$ Million)
    Table 65. Europe Obesity Treating Neuromodulation System Sales by Application (2017-2022) & (K Units)
    Table 66. Europe Obesity Treating Neuromodulation System Sales by Application (2023-2028) & (K Units)
    Table 67. Europe Obesity Treating Neuromodulation System Revenue by Application (2017-2022) & (US$ Million)
    Table 68. Europe Obesity Treating Neuromodulation System Revenue by Application (2023-2028) & (US$ Million)
    Table 69. Europe Obesity Treating Neuromodulation System Sales by Country (2017-2022) & (K Units)
    Table 70. Europe Obesity Treating Neuromodulation System Sales by Country (2023-2028) & (K Units)
    Table 71. Europe Obesity Treating Neuromodulation System Revenue by Country (2017-2022) & (US$ Million)
    Table 72. Europe Obesity Treating Neuromodulation System Revenue by Country (2023-2028) & (US$ Million)
    Table 73. Asia Pacific Obesity Treating Neuromodulation System Sales by Type (2017-2022) & (K Units)
    Table 74. Asia Pacific Obesity Treating Neuromodulation System Sales by Type (2023-2028) & (K Units)
    Table 75. Asia Pacific Obesity Treating Neuromodulation System Revenue by Type (2017-2022) & (US$ Million)
    Table 76. Asia Pacific Obesity Treating Neuromodulation System Revenue by Type (2023-2028) & (US$ Million)
    Table 77. Asia Pacific Obesity Treating Neuromodulation System Sales by Application (2017-2022) & (K Units)
    Table 78. Asia Pacific Obesity Treating Neuromodulation System Sales by Application (2023-2028) & (K Units)
    Table 79. Asia Pacific Obesity Treating Neuromodulation System Revenue by Application (2017-2022) & (US$ Million)
    Table 80. Asia Pacific Obesity Treating Neuromodulation System Revenue by Application (2023-2028) & (US$ Million)
    Table 81. Asia Pacific Obesity Treating Neuromodulation System Sales by Region (2017-2022) & (K Units)
    Table 82. Asia Pacific Obesity Treating Neuromodulation System Sales by Region (2023-2028) & (K Units)
    Table 83. Asia Pacific Obesity Treating Neuromodulation System Revenue by Region (2017-2022) & (US$ Million)
    Table 84. Asia Pacific Obesity Treating Neuromodulation System Revenue by Region (2023-2028) & (US$ Million)
    Table 85. Latin America Obesity Treating Neuromodulation System Sales by Type (2017-2022) & (K Units)
    Table 86. Latin America Obesity Treating Neuromodulation System Sales by Type (2023-2028) & (K Units)
    Table 87. Latin America Obesity Treating Neuromodulation System Revenue by Type (2017-2022) & (US$ Million)
    Table 88. Latin America Obesity Treating Neuromodulation System Revenue by Type (2023-2028) & (US$ Million)
    Table 89. Latin America Obesity Treating Neuromodulation System Sales by Application (2017-2022) & (K Units)
    Table 90. Latin America Obesity Treating Neuromodulation System Sales by Application (2023-2028) & (K Units)
    Table 91. Latin America Obesity Treating Neuromodulation System Revenue by Application (2017-2022) & (US$ Million)
    Table 92. Latin America Obesity Treating Neuromodulation System Revenue by Application (2023-2028) & (US$ Million)
    Table 93. Latin America Obesity Treating Neuromodulation System Sales by Country (2017-2022) & (K Units)
    Table 94. Latin America Obesity Treating Neuromodulation System Sales by Country (2023-2028) & (K Units)
    Table 95. Latin America Obesity Treating Neuromodulation System Revenue by Country (2017-2022) & (US$ Million)
    Table 96. Latin America Obesity Treating Neuromodulation System Revenue by Country (2023-2028) & (US$ Million)
    Table 97. Middle East and Africa Obesity Treating Neuromodulation System Sales by Type (2017-2022) & (K Units)
    Table 98. Middle East and Africa Obesity Treating Neuromodulation System Sales by Type (2023-2028) & (K Units)
    Table 99. Middle East and Africa Obesity Treating Neuromodulation System Revenue by Type (2017-2022) & (US$ Million)
    Table 100. Middle East and Africa Obesity Treating Neuromodulation System Revenue by Type (2023-2028) & (US$ Million)
    Table 101. Middle East and Africa Obesity Treating Neuromodulation System Sales by Application (2017-2022) & (K Units)
    Table 102. Middle East and Africa Obesity Treating Neuromodulation System Sales by Application (2023-2028) & (K Units)
    Table 103. Middle East and Africa Obesity Treating Neuromodulation System Revenue by Application (2017-2022) & (US$ Million)
    Table 104. Middle East and Africa Obesity Treating Neuromodulation System Revenue by Application (2023-2028) & (US$ Million)
    Table 105. Middle East and Africa Obesity Treating Neuromodulation System Sales by Country (2017-2022) & (K Units)
    Table 106. Middle East and Africa Obesity Treating Neuromodulation System Sales by Country (2023-2028) & (K Units)
    Table 107. Middle East and Africa Obesity Treating Neuromodulation System Revenue by Country (2017-2022) & (US$ Million)
    Table 108. Middle East and Africa Obesity Treating Neuromodulation System Revenue by Country (2023-2028) & (US$ Million)
    Table 109. Medtronic Corporation Information
    Table 110. Medtronic Description and Major Businesses
    Table 111. Medtronic Obesity Treating Neuromodulation System Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 112. Medtronic Obesity Treating Neuromodulation System Product Model Numbers, Pictures, Descriptions and Specifications
    Table 113. Medtronic Recent Developments
    Table 114. Cyberonics Corporation Information
    Table 115. Cyberonics Description and Major Businesses
    Table 116. Cyberonics Obesity Treating Neuromodulation System Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 117. Cyberonics Obesity Treating Neuromodulation System Product Model Numbers, Pictures, Descriptions and Specifications
    Table 118. Cyberonics Recent Developments
    Table 119. Abbott Corporation Information
    Table 120. Abbott Description and Major Businesses
    Table 121. Abbott Obesity Treating Neuromodulation System Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 122. Abbott Obesity Treating Neuromodulation System Product Model Numbers, Pictures, Descriptions and Specifications
    Table 123. Abbott Recent Developments
    Table 124. BioControl Medical Corporation Information
    Table 125. BioControl Medical Description and Major Businesses
    Table 126. BioControl Medical Obesity Treating Neuromodulation System Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 127. BioControl Medical Obesity Treating Neuromodulation System Product Model Numbers, Pictures, Descriptions and Specifications
    Table 128. BioControl Medical Recent Developments
    Table 129. Leptos Medical Corporation Information
    Table 130. Leptos Medical Description and Major Businesses
    Table 131. Leptos Medical Obesity Treating Neuromodulation System Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 132. Leptos Medical Obesity Treating Neuromodulation System Product Model Numbers, Pictures, Descriptions and Specifications
    Table 133. Leptos Medical Recent Developments
    Table 134. ReShape Lifesciences Corporation Information
    Table 135. ReShape Lifesciences Description and Major Businesses
    Table 136. ReShape Lifesciences Obesity Treating Neuromodulation System Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 137. ReShape Lifesciences Obesity Treating Neuromodulation System Product Model Numbers, Pictures, Descriptions and Specifications
    Table 138. ReShape Lifesciences Recent Developments
    Table 139. Nevro Corporation Information
    Table 140. Nevro Description and Major Businesses
    Table 141. Nevro Obesity Treating Neuromodulation System Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 142. Nevro Obesity Treating Neuromodulation System Product Model Numbers, Pictures, Descriptions and Specifications
    Table 143. Nevro Recent Developments
    Table 144. Nuvectra Corporation Information
    Table 145. Nuvectra Description and Major Businesses
    Table 146. Nuvectra Obesity Treating Neuromodulation System Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 147. Nuvectra Obesity Treating Neuromodulation System Product Model Numbers, Pictures, Descriptions and Specifications
    Table 148. Nuvectra Recent Developments
    Table 149. Key Raw Materials Lists
    Table 150. Raw Materials Key Suppliers Lists
    Table 151. Obesity Treating Neuromodulation System Distributors List
    Table 152. Obesity Treating Neuromodulation System Customers List
    Table 153. Obesity Treating Neuromodulation System Market Trends
    Table 154. Obesity Treating Neuromodulation System Market Drivers
    Table 155. Obesity Treating Neuromodulation System Market Challenges
    Table 156. Obesity Treating Neuromodulation System Market Restraints
    Table 157. Research Programs/Design for This Report
    Table 158. Key Data Information from Secondary Sources
    Table 159. Key Data Information from Primary Sources
List of Figures
    Figure 1. Obesity Treating Neuromodulation System Product Picture
    Figure 3. Global Obesity Treating Neuromodulation System Market Share by Type in 2021 & 2028
    Figure 3. Vagus Nerve Stimulator Product Picture
    Figure 4. Splanchnic Nerve Stimulator Product Picture
    Figure 5. Deep Brain Stimulator Product Picture
    Figure 6. Spinal Cord Stimulator Product Picture
    Figure 7. Autonomous Nerve Stimulator Product Picture
    Figure 8. Others Product Picture
    Figure 9. Global Obesity Treating Neuromodulation System Market Share by Application in 2021 & 2028
    Figure 10. Hospitals
    Figure 11. Clinics
    Figure 12. Ambulatory Surgical Centers
    Figure 13. Obesity Treating Neuromodulation System Report Years Considered
    Figure 14. Global Obesity Treating Neuromodulation System Sales 2017-2028 (K Units)
    Figure 15. Global Obesity Treating Neuromodulation System Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 16. Global Obesity Treating Neuromodulation System Revenue 2017-2028 (US$ Million)
    Figure 17. Global Obesity Treating Neuromodulation System Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 18. Global Obesity Treating Neuromodulation System Sales Market Share by Region (2017-2022)
    Figure 19. Global Obesity Treating Neuromodulation System Sales Market Share by Region (2023-2028)
    Figure 20. North America Obesity Treating Neuromodulation System Sales YoY (2017-2028) & (K Units)
    Figure 21. North America Obesity Treating Neuromodulation System Revenue YoY (2017-2028) & (US$ Million)
    Figure 22. Europe Obesity Treating Neuromodulation System Sales YoY (2017-2028) & (K Units)
    Figure 23. Europe Obesity Treating Neuromodulation System Revenue YoY (2017-2028) & (US$ Million)
    Figure 24. Asia-Pacific Obesity Treating Neuromodulation System Sales YoY (2017-2028) & (K Units)
    Figure 25. Asia-Pacific Obesity Treating Neuromodulation System Revenue YoY (2017-2028) & (US$ Million)
    Figure 26. Latin America Obesity Treating Neuromodulation System Sales YoY (2017-2028) & (K Units)
    Figure 27. Latin America Obesity Treating Neuromodulation System Revenue YoY (2017-2028) & (US$ Million)
    Figure 28. Middle East & Africa Obesity Treating Neuromodulation System Sales YoY (2017-2028) & (K Units)
    Figure 29. Middle East & Africa Obesity Treating Neuromodulation System Revenue YoY (2017-2028) & (US$ Million)
    Figure 30. The Obesity Treating Neuromodulation System Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 31. The Top 5 and 10 Largest Manufacturers of Obesity Treating Neuromodulation System in the World: Market Share by Obesity Treating Neuromodulation System Revenue in 2021
    Figure 32. Global Obesity Treating Neuromodulation System Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 33. Global Obesity Treating Neuromodulation System Sales Market Share by Type (2017-2028)
    Figure 34. Global Obesity Treating Neuromodulation System Revenue Market Share by Type (2017-2028)
    Figure 35. Global Obesity Treating Neuromodulation System Sales Market Share by Application (2017-2028)
    Figure 36. Global Obesity Treating Neuromodulation System Revenue Market Share by Application (2017-2028)
    Figure 37. North America Obesity Treating Neuromodulation System Sales Market Share by Type (2017-2028)
    Figure 38. North America Obesity Treating Neuromodulation System Revenue Market Share by Type (2017-2028)
    Figure 39. North America Obesity Treating Neuromodulation System Sales Market Share by Application (2017-2028)
    Figure 40. North America Obesity Treating Neuromodulation System Revenue Market Share by Application (2017-2028)
    Figure 41. North America Obesity Treating Neuromodulation System Sales Share by Country (2017-2028)
    Figure 42. North America Obesity Treating Neuromodulation System Revenue Share by Country (2017-2028)
    Figure 43. U.S. Obesity Treating Neuromodulation System Revenue (2017-2028) & (US$ Million)
    Figure 44. Canada Obesity Treating Neuromodulation System Revenue (2017-2028) & (US$ Million)
    Figure 45. Europe Obesity Treating Neuromodulation System Sales Market Share by Type (2017-2028)
    Figure 46. Europe Obesity Treating Neuromodulation System Revenue Market Share by Type (2017-2028)
    Figure 47. Europe Obesity Treating Neuromodulation System Sales Market Share by Application (2017-2028)
    Figure 48. Europe Obesity Treating Neuromodulation System Revenue Market Share by Application (2017-2028)
    Figure 49. Europe Obesity Treating Neuromodulation System Sales Share by Country (2017-2028)
    Figure 50. Europe Obesity Treating Neuromodulation System Revenue Share by Country (2017-2028)
    Figure 51. Germany Obesity Treating Neuromodulation System Revenue (2017-2028) & (US$ Million)
    Figure 52. France Obesity Treating Neuromodulation System Revenue (2017-2028) & (US$ Million)
    Figure 53. U.K. Obesity Treating Neuromodulation System Revenue (2017-2028) & (US$ Million)
    Figure 54. Italy Obesity Treating Neuromodulation System Revenue (2017-2028) & (US$ Million)
    Figure 55. Russia Obesity Treating Neuromodulation System Revenue (2017-2028) & (US$ Million)
    Figure 56. Asia Pacific Obesity Treating Neuromodulation System Sales Market Share by Type (2017-2028)
    Figure 57. Asia Pacific Obesity Treating Neuromodulation System Revenue Market Share by Type (2017-2028)
    Figure 58. Asia Pacific Obesity Treating Neuromodulation System Sales Market Share by Application (2017-2028)
    Figure 59. Asia Pacific Obesity Treating Neuromodulation System Revenue Market Share by Application (2017-2028)
    Figure 60. Asia Pacific Obesity Treating Neuromodulation System Sales Share by Region (2017-2028)
    Figure 61. Asia Pacific Obesity Treating Neuromodulation System Revenue Share by Region (2017-2028)
    Figure 62. China Obesity Treating Neuromodulation System Revenue (2017-2028) & (US$ Million)
    Figure 63. Japan Obesity Treating Neuromodulation System Revenue (2017-2028) & (US$ Million)
    Figure 64. South Korea Obesity Treating Neuromodulation System Revenue (2017-2028) & (US$ Million)
    Figure 65. India Obesity Treating Neuromodulation System Revenue (2017-2028) & (US$ Million)
    Figure 66. Australia Obesity Treating Neuromodulation System Revenue (2017-2028) & (US$ Million)
    Figure 67. Taiwan Obesity Treating Neuromodulation System Revenue (2017-2028) & (US$ Million)
    Figure 68. Indonesia Obesity Treating Neuromodulation System Revenue (2017-2028) & (US$ Million)
    Figure 69. Thailand Obesity Treating Neuromodulation System Revenue (2017-2028) & (US$ Million)
    Figure 70. Malaysia Obesity Treating Neuromodulation System Revenue (2017-2028) & (US$ Million)
    Figure 71. Philippines Obesity Treating Neuromodulation System Revenue (2017-2028) & (US$ Million)
    Figure 72. Latin America Obesity Treating Neuromodulation System Sales Market Share by Type (2017-2028)
    Figure 73. Latin America Obesity Treating Neuromodulation System Revenue Market Share by Type (2017-2028)
    Figure 74. Latin America Obesity Treating Neuromodulation System Sales Market Share by Application (2017-2028)
    Figure 75. Latin America Obesity Treating Neuromodulation System Revenue Market Share by Application (2017-2028)
    Figure 76. Latin America Obesity Treating Neuromodulation System Sales Share by Country (2017-2028)
    Figure 77. Latin America Obesity Treating Neuromodulation System Revenue Share by Country (2017-2028)
    Figure 78. Mexico Obesity Treating Neuromodulation System Revenue (2017-2028) & (US$ Million)
    Figure 79. Brazil Obesity Treating Neuromodulation System Revenue (2017-2028) & (US$ Million)
    Figure 80. Argentina Obesity Treating Neuromodulation System Revenue (2017-2028) & (US$ Million)
    Figure 81. Middle East and Africa Obesity Treating Neuromodulation System Sales Market Share by Type (2017-2028)
    Figure 82. Middle East and Africa Obesity Treating Neuromodulation System Revenue Market Share by Type (2017-2028)
    Figure 83. Middle East and Africa Obesity Treating Neuromodulation System Sales Market Share by Application (2017-2028)
    Figure 84. Middle East and Africa Obesity Treating Neuromodulation System Revenue Market Share by Application (2017-2028)
    Figure 85. Middle East and Africa Obesity Treating Neuromodulation System Sales Share by Country (2017-2028)
    Figure 86. Middle East and Africa Obesity Treating Neuromodulation System Revenue Share by Country (2017-2028)
    Figure 87. Turkey Obesity Treating Neuromodulation System Revenue (2017-2028) & (US$ Million)
    Figure 88. Saudi Arabia Obesity Treating Neuromodulation System Revenue (2017-2028) & (US$ Million)
    Figure 89. UAE Obesity Treating Neuromodulation System Revenue (2017-2028) & (US$ Million)
    Figure 90. Obesity Treating Neuromodulation System Value Chain
    Figure 91. Obesity Treating Neuromodulation System Production Process
    Figure 92. Channels of Distribution
    Figure 93. Distributors Profiles
    Figure 94. Bottom-up and Top-down Approaches for This Report
    Figure 95. Data Triangulation
    Figure 96. Key Executives Interviewed